{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:13:39Z","timestamp":1732043619516},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,6]]},"DOI":"10.7759\/cureus.68766","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:32:10Z","timestamp":1725611530000},"source":"Crossref","is-referenced-by-count":1,"title":["Ischaemic Cardiomyopathy Secondary to Asymptomatic Coronary Artery Disease: A Case Report"],"prefix":"10.7759","author":[{"given":"Gedoni","family":"Eni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshan","family":"Faiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhiamluka","family":"Solano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1747","article-title":"Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology","volume":"22","author":"Cabac-Pogorevici I","year":"2020","unstructured":"Cabac-Pogorevici I, Muk B, Rustamova Y, Kalogeropoulos A, Tzeis S, Vardas P. Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology. Eur J Heart Fail. 2020, 22:789-99. 10.1002\/ejhf.1747","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott P","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, et al.. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008, 29:270-6. 10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000088001.59265.EE","article-title":"Silent myocardial ischemia","volume":"108","author":"Cohn PF","year":"2003","unstructured":"Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation. 2003, 108:1263-77. 10.1161\/01.CIR.0000088001.59265.EE","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot G","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, et al.. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013, 34:2949-3003. 10.1093\/eurheartj\/eht296","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh TA","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023, 44:3627-39. 10.1093\/eurheartj\/ehad195","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs332","article-title":"Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure","volume":"34","author":"Nikolaou M","year":"2013","unstructured":"Nikolaou M, Parissis J, Yilmaz MB, et al.. Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J. 2013, 34:742-9. 10.1093\/eurheartj\/ehs332","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.10.016","article-title":"Liver disease and heart failure: back and forth","volume":"48","author":"Correale M","year":"2018","unstructured":"Correale M, Tarantino N, Petrucci R, Tricarico L, Laonigro I, Di Biase M, Brunetti ND. Liver disease and heart failure: back and forth. Eur J Intern Med. 2018, 48:25-34. 10.1016\/j.ejim.2017.10.016","journal-title":"Eur J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.10.007","article-title":"Heart failure and liver disease: cardiohepatic interactions","volume":"7","author":"Xanthopoulos A","year":"2019","unstructured":"Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019, 7:87-97. 10.1016\/j.jchf.2018.10.007","journal-title":"JACC Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.070","article-title":"Contemporary management of severe\u00a0acute kidney injury and refractory cardiorenal syndrome: JACC Council Perspectives","volume":"76","author":"Jentzer JC","year":"2020","unstructured":"Jentzer JC, Bihorac A, Brusca SB, et al.. Contemporary management of severe\u00a0acute kidney injury and refractory cardiorenal syndrome: JACC Council Perspectives. J Am Coll Cardiol. 2020, 76:1084-101. 10.1016\/j.jacc.2020.06.070","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092364","article-title":"Cardiovascular consequences of acute kidney injury: treatment options","volume":"11","author":"Voicehovska JG","year":"2023","unstructured":"Voicehovska JG, Trumpika D, Voicehovskis VV, et al.. Cardiovascular consequences of acute kidney injury: treatment options. Biomedicines. 2023, 11:2364. 10.3390\/biomedicines11092364","journal-title":"Biomedicines"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15156","article-title":"Effect of diuretics on plasma aldosterone and potassium in primary hypertension: a systematic review and meta-analysis","volume":"88","author":"McNally RJ","year":"2022","unstructured":"McNally RJ, Farukh B, Chowienczyk PJ, Faconti L. Effect of diuretics on plasma aldosterone and potassium in primary hypertension: a systematic review and meta-analysis. Br J Clin Pharmacol. 2022, 88:1964-77. 10.1111\/bcp.15156","journal-title":"Br J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314158","article-title":"Change in renal function associated with drug treatment in heart failure: national guidance","volume":"105","author":"Clark AL","year":"2019","unstructured":"Clark AL, Kalra PR, Petrie MC, Mark PB, Tomlinson LA, Tomson CR. Change in renal function associated with drug treatment in heart failure: national guidance. Heart. 2019, 105:904-10. 10.1136\/heartjnl-2018-314158","journal-title":"Heart"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/suaa141","article-title":"Old unsolved problems: when and how to treat silent ischaemia","volume":"22","author":"Indolfi C","year":"2020","unstructured":"Indolfi C, Polimeni A, Mongiardo A, De Rosa S, Spaccarotella C. Old unsolved problems: when and how to treat silent ischaemia. Eur Heart J Suppl. 2020, 22:L82-5. 10.1093\/eurheartj\/suaa141","journal-title":"Eur Heart J Suppl"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020259","article-title":"Silent myocardial ischemia: from pathophysiology to diagnosis and treatment","volume":"12","author":"Theofilis P","year":"2024","unstructured":"Theofilis P, Antonopoulos AS, Sagris M, Papanikolaou A, Oikonomou E, Tsioufis K, Tousoulis D. Silent myocardial ischemia: from pathophysiology to diagnosis and treatment. Biomedicines. 2024, 12:259. 10.3390\/biomedicines12020259","journal-title":"Biomedicines"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo E","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, et al.. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023, 44:3503-626. 10.1093\/eurheartj\/ehad194","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson P","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, et al.. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996, 93:841-2. 10.1161\/01.cir.93.5.841","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results","volume":"1","author":"Carson P","year":"2013","unstructured":"Carson P, Wertheimer J, Miller A, et al.. The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. JACC Heart Fail. 2013, 1:400-8. 10.1016\/j.jchf.2013.04.012","journal-title":"JACC Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera D","year":"2022","unstructured":"Perera D, Clayton T, O'Kane PD, et al.. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022, 387:1351-60. 10.1056\/NEJMoa2206606","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","author":"Vrints C","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al.. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024, ehae177. 10.1093\/eurheartj\/ehae177","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/292331-ischaemic-cardiomyopathy-secondary-to-asymptomatic-coronary-artery-disease-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T08:32:13Z","timestamp":1725611533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/292331-ischaemic-cardiomyopathy-secondary-to-asymptomatic-coronary-artery-disease-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.68766","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}